Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
28 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
Rank Status Study
21 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
22 Unknown  Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
Condition: Peptic Ulcer
Intervention: Drug: esomeprazole
23 Unknown  Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy
Conditions: Pancreatic Neoplasms;   Bile Duct Neoplasms;   Ampullary Neoplasms;   Duodenal Neoplasms;   Pancreatitis
Interventions: Procedure: Billroth-II-type reconstruction;   Procedure: Isolated Roux-en-Y type reconstruction
24 Recruiting The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: esomeprazole or pantoprazole;   Procedure: Endoscopic hemostasis
25 Unknown  Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor
Conditions: Peptic Ulcer;   Ulcer Complications
Interventions: Drug: lansoprazole;   Drug: aluminum hydroxide 334 mg and Mg hydroxide 166 mg
26 Recruiting The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding and the Selection Criteria for Second-look Endoscopy for Patients With Bleeding Peptic Ulcers
Condition: Peptic Ulcer Bleeding
Intervention: Drug: esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden)
27 Recruiting Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Condition: Bleeding Peptic Ulcers
Intervention: Device: Hemospray Kit
28 Recruiting Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Conditions: Gastritis;   Peptic Ulcer Disease;   Cholangiopathy;   Liver Fibrosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-28) Next Page   
Indicates status has not been verified in more than two years